$IBM surges 11% as Commerce Dept awards $1B CHIPS Act quantum foundry grant
Original: IBM just scored a $26 billion quantum windfall — and the stock's rally isn't over View original →
Deal Overview
The U.S. Commerce Department on May 22, 2026 awarded IBM a $1 billion grant under the CHIPS and Science Act's quantum computing sub-program, triggering an 11% single-session surge in $IBM shares and a $26 billion market cap gain. IBM will match the federal grant dollar-for-dollar, committing $1 billion of its own capital, for a total $2 billion investment in the Albany, New York facility named "Anderon."
What Anderon Is
Anderon will be America's first pure-play, dedicated 300mm quantum chip manufacturing foundry. Unlike conventional fabs that handle a mixed workload of logic and memory chips, the Albany facility is designed exclusively for quantum processors. The 300mm wafer platform — the same form factor used in high-volume classical semiconductor production — aims to bring manufacturing-scale cost efficiencies to quantum devices, a milestone the industry has yet to reach commercially.
Policy Context
The CHIPS and Science Act authorized $52 billion to rebuild U.S. semiconductor manufacturing. IBM's grant is drawn from a $2 billion sub-program dedicated specifically to quantum computing — separate from classical chip grants previously allocated to Intel, TSMC, and Samsung Electronics. Washington's dedicated quantum tranche signals intent to build a domestic quantum hardware manufacturing base independent of existing foundry networks.
Near-Term Financials
No immediate revenue impact is expected. IBM's Q2 FY2026 earnings (scheduled July–August 2026) will not reflect Anderon-related revenue, as the facility requires years to complete. The 11% stock reaction implies the market is pricing in strategic positioning value — IBM's designation as the anchor supplier for U.S. government quantum hardware procurement pipelines — rather than near-term cash flows.
What to Watch
- July–August 2026: IBM Q2 earnings — quantum business order-book disclosures
- Albany site regulatory approvals and groundbreaking timeline
- Allocation of remaining $1 billion in the CHIPS quantum sub-program
Source: Yahoo Finance
Not investment advice. Verify all figures with primary sources before acting.
Related Articles
IBM $IBM fell 6% in extended trading after first-quarter adjusted EPS of $1.91 and revenue of $15.92B beat expectations of $1.81 and $15.62B. The stock reaction turned negative because management kept its 2026 outlook unchanged instead of raising targets after a 9% revenue gain.
G7 finance ministers are meeting in Paris on May 18–19 as the prolonged Strait of Hormuz closure drives global oil inventories toward all-time lows by the end of May, according to UBS. The gathering comes as long-term borrowing costs surge across G7 economies and Eurogroup head Pascal Donohoe called opening the Strait 'of utmost importance.'
A majority of SpaceX shareholders have approved a board-recommended 5-for-1 stock split, Bloomberg reported, in a move widely read as an IPO preparatory step for one of the world's most valuable private companies. The announcement follows Cerebras's blockbuster +70% IPO debut, intensifying investor anticipation for the SpaceX, OpenAI, and Anthropic public listings.
Comments (0)
No comments yet. Be the first to comment!